Tour-de-Force

More documents

Recommendations

Info

Tour-de-Force: Interplay between Mitochondria and Cell Cycle Progression Fall 2007ReferencesArticlesAlirol, E. and Martinou, JC. (2006) “Mitochondria and cancer: is there a morphological connection?”, Oncogene 25, 4706-4716.Arakaki, N et al. (2006) “Dynamics of Mitochondria during the Cell Cycle”, Biology and Pharmacology Bulletins 29, 1962-1965.Ashburner, M. and Bonnert, J.J. (1979) “The induction of gene activity in Drosophila by heat shock”, Cell 17, 241-254.Berg, J.M.; Tymoczko, J.L. and Stryer, L. (2006) Biochemistry, W.H. Freeman & Co Ltd., New YorkBlomen, V.A. and Boonstra, J. (2007) "Cell fate determination during G1 phase progression" Cellular and Molecular Life Sciences,Published Online, 1-21.Bokko, P.B. et al. (2007) "Diverse Cytopathologies in Mitochondrial Disease Are Caused by AMP-activated Protein Kinase Signaling",Molecular Biology of the Cell 18, 1874-1886.Boom, R. et al. (1988) “Induction of gene expression under human cytomegalovirus immediate enhancer-promoter control byinhibition of protein synthesis is cell cycle dependent”, Journal of General Virology 69, 1179-1193.Brand, K. et al. (1997) “Aerobic glycolysis by proliferating cells: protection against oxidative stress at the expense of energy yield”.Journal of Bioenergetics and Biomembranes 29, 355-364.Chen, H. and Chan, D. (2005) "Emerging functions of mammalian mitochondrial fusion and fission", Human Molecular Genetics 14,283-289.Cooper, G.M. and Hausman, R.E. (2007) “The Cell: A Molecular Approach”, Sinauer, 4 th ed.Cribbs, J. and Strack, S. (2007) “Reversible phosphorylation of Drp1 by cyclic AMP-dependent protein kinase and calcineurinregulates mitochondrial fission and cell death”, EMBO Reports 8, 939-944.Desai; Myers; Schreiber, (2002), “FKBP12-Rapamycin-Associated Protein Associates with Mitochondria and Senses Osmotic Stressvia Mitochondrial Dysfunction”, Proceedings of the National Academy of Sciences of the United States of America (PNAS), 99, 4319-4324.Dorward, Sweet, Moorehead and Singh (1997) “Mitochondrial Contributions to Cancer Cell Physiology: Redox Balance, Cell Cycle,and Drug Resistance”, Journal of bioenergetics and biomembrane, 29, pp: 385-392.Fesik, S.W. and Shi, Y. (2001) "Controlling the caspases", Science 294, 5546.Frauwirth, K.A. and Thompson, C.B. (2004) “Regulation of T-lymphocyte metabolism”, The Journal of Immunology 172, 4661-4665.Hardie, D.G. (2005) "New roles for the LKB1->AMPK pathway", Current Opinion in Cell Biology 17, 167-173.Hardie, D. (2007) “AMP-activated/SNF1 protein kinases: conserved guardians of cellular energy”, Nature Reviews 8, 774-785.Hawley, S. et al. (1996) “Characterization of the AMP-activated protein kinase from rat liver and identification of threonine 172 as themajor site at which it phosphoylates AMP-activated protein kinase”, Journal of Biological Chemistry 271, 27879-27887.Hoppins, S. et al. (2007) “The machines that divide and fuse Mitochondria”, Annual Reviews in Biochemistry 76, 751-780.Hue, L. et al. (2003) “AMP-activated protein kinase (AMPK) control of fatty acid and glucose metabolism in the ischemic heart”,Biochem. Soc. Trans. 31, 213-215.Hulleman, E. et al. (2004). “Identification of a restriction point at the G1/M transition in CHO cells”, Molecular Life Science, 61, 600-609.Hulleman, E. and Boonstra, J. (2000) “Regulation of G1 phase progression by growth factors and the extracellular matrix”, Cell. Mol.Life Sci. 58, 80-93.Huss, R. et al. (2000) “Quiescence of CD34-Negative hematopoietic stem cells is mediated by downregulation of Cyclin B and noStat activation”, Cytokine 12, 1195-1204.Hwang et al., (2004) “AMP-Activated Protein Kinase activity is required for vanadate-induced hypoxia-inducible factor 1α expressionin DU145 cells”, Carcinogenesis, 25, 2497-2507.Jones, R.G. et al. (2005) "AMP-Activated Protein Kinase induces a p53-dependent metabolic checkpoint", Molecular Cell 18, 283-293.Kaushik, V.K. et al. (2001) "Regulation of fatty acid oxidation and glucose metabolism in rat soleus muscle: effects of AICAR" Am JPhysiol Endocrinol Metab 281, E335-E340.Kühn, et al. (1974) “Kinetic properties of the phosphofructokinase from erythrocytes of rats and rabbits. 2. The influence of effectorsunder Nearly Cellular Conditions” European Journal of Biochemistry 43, 443-450.Kulawiec, M. et al. (2006) “Proteomics analysis of mitochondria-to-nucleus retrograde response in human cancer”, Cancer Biology &Therapy 5, 967-975.Long, Y.C. et al. (2006). AMP-activated protein kinase signaling in metabolic regulation. Journal of Clinical Investigation 116, 1776.SCI 332 Advanced Molecular Cell Biology Research Proposal 54
Tour-de-Force: Interplay between Mitochondria and Cell Cycle Progression Fall 2007Mandal, S. et al. (2005) "Mitochondrial regulation of cell cycle progression during evelopment as revealed by the tenured mutation indrosophila", Developmental Cell 9, 843-854.Margineantu, D.H. et al. (2002) “Cell cycle dependent morphology changes and associated mitochondrial DNA redistribution inmitochondria of human cell lines”, Mitochondrion 1, 425-435.Martínez-Diez et al. (2006) "Biogenesis and dynamics of mitochondria during the cell cycle: significance of 3' UTRs", Plosone 1, 1-12.McBride, H.M.; Neuspiel, M. and Wasiak, S. (2006) "Mitochondria: More Than Just a Powerhouse" Current Biology Vol. 16, Issue14, R551-R560Min Wu et al. (2007) “Multiparameter metabolic analysis reveals a close link between attenuated mitochondrial bioenergetic functionand enhanced glycolysis dependency in human tumor cells”, American Journal of Physiology and Cell Physiology, 61, C125-137.Norbury, C. and Nurse, P. (1992) “Animal cell cycles and their control”, Annual Review of Biochemistry 61, 441-470.Pajalunga et al. (2007). Critical requirements for cell cycle inhibitors in sustaining non-proliferative states, Cell Biology 176, 807-818.Pinilla and Luque (1977) “Activation of rat erythrocyte phosphofructokinase by AMP and by nonphysiological concentrations of cyclicAMP”, Molecular & Cellular Biochemistry,15.Rube, D. and Van der Bliek, A. (2004) “Mitochondrial morphology is dynamic and varied”, Molecular and Cellular Biochemistry256/257, 331-339.Sabbagh, E. et al. (1985) “3-Mercaptopropionic acid, a potent inhibitor of fatty acid oxidation in rat heart mitochondria” Journal ofBiology and Chemistry 260, 7337-7342.Schobel, U. (1999) “New donor-acceptor pair for fluorescent immunoassays by energy transfer”, Bioconjugate Chemistry 10, 1107-1114.Schomber, T. et al. (2004) "Gene silencing by lentivirus-mediated delivery of siRNA in human CD34+ cells" Blood 103, 4511-4513Schorl, C. et al. (2003) “Loss of protooncogene c-Myc function impedes G1-phase progression both before and after the restrictionpoint”, Molecular Biology of the Cell 14, 823–835.Sekito, T.; Thornton, J.; Butow, R.A.; (2000), “Mitochondria-to-nuclear Signalling is regulated by the Subcellular localization of thetranscription factors Rtg1p and Rtg3p”, Molecular Biology of the Cel, 11 pp: 2103–2115Singh, (2004) “Mitochondria damage checkpoint in apoptosis and genome stability”, FEMS yeast research, 5, pp: 127-132Sun, Y. et al. (2007) “AICAR induces phosphorylation of AMPK in an ATM-dependent, LKB1-independent manner”, Molecular andCellular Biochemistry 306, 239–245.Suzuki, A. et al. (2007) "Leptin Stimulates Fatty Acid Oxidation and Peroxisome Proliferator-Activated Receptor α Gene Expressionin Mouse C2C12 Myoblasts by Changing the Subcellular Localization of the α2 Form of AMP-Activated Protein Kinase" Molecularand Cellular Biology 27, 4317-4327.Taguchi et al. (2007) “Mitotic phosphorylation of dynamin-related GTPase Drp1 participates in mitochondrial fission”, Journal ofBiological Chemistry 282, 11521-11529.Tzatsos, A. and Tsichlis, P.N. (2007). Energy Depletion Inhibits Phosphatidylinositol 3-Kinase/Akt Signaling and Induces Apoptosisvia AMP-activated Protein Kinase-dependent Phosphorylation of IRS-1 at Ser-794. Journal of Biological Chemistry , 282 (25), 1074.Violett, B. et al. (2003a) “Physiological role of AMP-activated protein kinase (AMPK): Insights from knockout mouse models”,Biochem. Soc. Trans. 31, 216-129.Violett, B. et al. (2003b) “The AMP-activated protein kinase a2 catalytic subunit controls whole-body insulin sensitivity”, Journal ofClinical Investigation 111, 91-98.Viollet, B. et al. (2006) “Activation of AMP-activated protein kinase in the liver: a new strategy for the management of metabolichepatic disorders”, Journal of Physiology 574, 41-53.Werf, M.J. van der et al. (2007) “Microbial metabolomics: toward a platform with full metabolome coverage”, Analytical BiochemistryVol. 370, Issue 1, 17-25.Westermann, B. (2002) “Merging mitochondria matters; cellular role and molecular machinery of mitochondrial fusion”, EMBOReports 3, 527-531.Woods, A. et al. (2000) “Characterization of the role of AMP-activated protein kinase in the regulation of glucose-activated geneexpression using constitutively active and dominant negative forms of the kinase”, Molecular and Cellular Biology 20, 6704-6711.Wu, M. et al. (2005) “A novel technology for profiling cell energy metabolism in cancer cells”, The 2nd International Conference onTumor Progression and Therapeutic Resistance, GCTbio, Boston.Xue, B. and Kahn, B.B. (2006) “AMPK integrates nutrient and hormonal signals to regulate food intake and energy balance througheffects in the hypothalamus and peripheral tissues”, Journal of Physiology 574, 73-83.Zhang, T., and Prives, C. (2001) "Cyclin A-CDK phosphorylation regulates MDM2 protein interactions", Journal of Biochemistry 276,29702-29710.SCI 332 Advanced Molecular Cell Biology Research Proposal 55
Page 1 and 2:
Tour-de-ForceInterplay between mito
Page 3 and 4: Tour-de-Force: Interplay between Mi
Page 53: Tour-de-Force: Interplay between Mi
Page 105 and 106:
Tour-de-Force: Interplay between Mi
Page 107 and 108:
Page 109 and 110:
Page 111 and 112:
Page 113 and 114:
Page 115 and 116:
Page 117 and 118:
show all

Tour-de-Force

Create successful ePaper yourself

Delete template?

Save as template?